A database of FDA approved therapeutic peptides and proteins
ID1038 | ThPPIDTh1007 | NameLeuprolide | Peptide SequencePHWSYLLR Full view | Length8 | Functional ClassificationIIa | DiseaseCancer | BrandEligard | CompanyAtrix Labs/QLT In | Physical AppearanceSuspension | Route of AdministartionSubcutaneous Injection | CategoryAntineoplastic Agents, Hormonal and fertility agents, estrogen antagonists | TargetGonadotropin-releasing hormone receptor |
ID1382 | ThPPIDTh1060 | NameInsulin, porcine | Peptide SequenceA chain: GIVEQCCTSIC Full view | Length51 | Functional ClassificationIa | DiseaseHormonal/Metabolic | Brandvetsulin | CompanyIntervet Inc (Merck Animal Health) | Physical AppearanceSterile injectable suspension in multidose vials containing 10 mL of 40 IU/mL porcine insulin zinc suspension | Route of AdministartionSubcutaneous Injection | CategoryHypoglycemic Agents | TargetInterferon alpha/beta receptor 2,Interferon alpha/beta receptor 1, Hyaluronan, Transforming growth factor beta-1 |
ID1503 | ThPPIDTh1105 | NameInsulin Aspart | Peptide SequenceA chain: GIVEQCCTSIC Full view | Length51 | Functional ClassificationIa | DiseaseHormonal/Metabolic | BrandNovoLog Mix 50/50 | CompanyNovo Nordisk | Physical AppearanceUniform, white, sterile suspension that contains insulin aspart | Route of AdministartionSubcutaneous injection | CategoryHypoglycemic Agents and Antidiabetic Agents | TargetInsulin receptor |
ID1504 | ThPPIDTh1105 | NameInsulin Aspart | Peptide SequenceA chain: GIVEQCCTSIC Full view | Length51 | Functional ClassificationIa | DiseaseHormonal/Metabolic | BrandNovoLog Mix 70/30 | CompanyNovo Nordisk | Physical AppearanceUniform, white, sterile suspension that contains insulin aspart 100 Units/mL. | Route of AdministartionSubcutaneous injection | CategoryHypoglycemic Agents and Antidiabetic Agents | TargetInsulin receptor |
ID1634 | ThPPIDTh1140 | NameInsulin, Isophane Or Nph Insulin (Neutral Protamine Hagedorn) | Peptide SequenceA chain: GIVEQCCTSIC Full view | Length51 | Functional ClassificationIa | DiseaseHormonal/Metabolic | BrandNovolin N | CompanyNovo Nordisk | Physical AppearanceNovolin N InnoLet (nph, human insulin isophane suspension 3 ml disposable prefilled syringe) | Route of AdministartionSubcutaneous injection | CategoryHypoglycemic Agents and Antidiabetic Agents | TargetInsulin receptor |
ID1641 | ThPPIDTh1146 | NameLucinactant | Peptide SequenceKLLLLKLLLLKLLLLKLLLL Full view | Length21 | Functional ClassificationIb | DiseaseGenetic | BrandSurfaxin | CompanyDiscovery Laboratories, Inc. | Physical AppearanceSuspension | Route of AdministartionIntratracheal administration | CategoryPulmonary surfactants | TargetN.A. |
ID1662 | ThPPIDTh1154 | NameOspA lipoprotein | Peptide SequenceMKKYLLGIGLILALIACKQN Full view | Length272 | Functional ClassificationIIIa | DiseaseInfectious | BrandLymerix | CompanySmithKline Beecham | Physical AppearanceSterile suspension | Route of AdministartionIntramuscular Injection | CategoryVaccines | TargetToll-like receptor 2 |
ID1706 | ThPPIDTh1169 | NameBeractant | Peptide SequenceNA Full view | Length0 | Functional ClassificationIa | DiseaseRespiratory | BrandSurvanta | CompanyAbb Vie Inc. | Physical AppearanceSuspension | Route of AdministartionEndotracheal | CategoryNA | TargetNA |
ID1707 | ThPPIDTh1169 | NameBeractant | Peptide SequenceNA Full view | Length0 | Functional ClassificationIa | DiseaseRespiratory Disorder | BrandSurvanta | CompanyAbbvie Corporation | Physical AppearanceSuspension | Route of AdministartionIntratracheal | CategoryNA | TargetNA |
ID1810 | ThPPIDTh1201 | NamePoractant alfa | Peptide SequenceNA Full view | Length0 | Functional ClassificationIa | DiseaseRespiratory Disorder | BrandCurosurf | CompanyChiesi USA, Inc | Physical AppearanceSuspension | Route of AdministartionEndotracheal | CategoryPulmonary Surfactants | Target |
ID1821 | ThPPIDTh1212 | NameInsulin Pork | Peptide SequenceA chain GIVEQCCTSICS Full view | Length68 | Functional ClassificationIa | DiseaseMetabolic Disorders | BrandIletin II | CompanyLilly | Physical Appearancesterile suspension | Route of AdministartionSubcutaneous | CategoryHypoglycemic Agents, Antidiabetic Agents | TargetInsulin receptor, Insulin-like growth factor 1 receptor, Insulin-degrading enzyme, HLA class II histocompatibility antigen, DQ alpha 2 chain, HLA class II histocompatibility antigen, DQ beta 1 chain, Retinoblastoma-associated protein, Cathepsin D, Carboxypeptidase E, Neuroendocrine convertase 2, Neuroendocrine convertase 1, Protein NOV homolog, Low-density lipoprotein receptor-related protein 2, Insulin-like growth factor-binding protein 7, Synaptotagmin-like protein 4, Cytochrome P450 1A2 |
ID1840 | ThPPIDTh1229 | NameHepatitis A Vaccine | Peptide SequenceNA Full view | Length0 | Functional ClassificationIIIa | DiseaseInfectious Disease | BrandAvaxim | CompanySanofi Pasteur Limited | Physical AppearanceSuspension | Route of AdministartionIntramuscular | CategoryVaccine | TargetNA |
ID1841 | ThPPIDTh1229 | NameHepatitis A Vaccine | Peptide SequenceNA Full view | Length0 | Functional ClassificationIIIa | DiseaseInfectious Disease | BrandHavrix | CompanyDispensing Solutions, Inc. | Physical AppearanceSuspension | Route of AdministartionIntramuscular | CategoryVaccine | TargetNA |